Cargando…
Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483366/ https://www.ncbi.nlm.nih.gov/pubmed/36700404 http://dx.doi.org/10.3324/haematol.2022.282144 |
| _version_ | 1785102363849129984 |
|---|---|
| author | Vandersmissen, Charlien Prieto, Cristina Gielen, Olga Jacobs, Kris Nittner, David Maertens, Johan Segers, Heidi Cools, Jan |
| author_facet | Vandersmissen, Charlien Prieto, Cristina Gielen, Olga Jacobs, Kris Nittner, David Maertens, Johan Segers, Heidi Cools, Jan |
| author_sort | Vandersmissen, Charlien |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10483366 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104833662023-09-08 Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia Vandersmissen, Charlien Prieto, Cristina Gielen, Olga Jacobs, Kris Nittner, David Maertens, Johan Segers, Heidi Cools, Jan Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-01-26 /pmc/articles/PMC10483366/ /pubmed/36700404 http://dx.doi.org/10.3324/haematol.2022.282144 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Vandersmissen, Charlien Prieto, Cristina Gielen, Olga Jacobs, Kris Nittner, David Maertens, Johan Segers, Heidi Cools, Jan Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia |
| title | Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia |
| title_full | Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia |
| title_fullStr | Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia |
| title_full_unstemmed | Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia |
| title_short | Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia |
| title_sort | combination therapy of a psen1-selective γ-secretase inhibitor with dexamethasone and an xpo1 inhibitor to target t-cell acute lymphoblastic leukemia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483366/ https://www.ncbi.nlm.nih.gov/pubmed/36700404 http://dx.doi.org/10.3324/haematol.2022.282144 |
| work_keys_str_mv | AT vandersmissencharlien combinationtherapyofapsen1selectivegsecretaseinhibitorwithdexamethasoneandanxpo1inhibitortotargettcellacutelymphoblasticleukemia AT prietocristina combinationtherapyofapsen1selectivegsecretaseinhibitorwithdexamethasoneandanxpo1inhibitortotargettcellacutelymphoblasticleukemia AT gielenolga combinationtherapyofapsen1selectivegsecretaseinhibitorwithdexamethasoneandanxpo1inhibitortotargettcellacutelymphoblasticleukemia AT jacobskris combinationtherapyofapsen1selectivegsecretaseinhibitorwithdexamethasoneandanxpo1inhibitortotargettcellacutelymphoblasticleukemia AT nittnerdavid combinationtherapyofapsen1selectivegsecretaseinhibitorwithdexamethasoneandanxpo1inhibitortotargettcellacutelymphoblasticleukemia AT maertensjohan combinationtherapyofapsen1selectivegsecretaseinhibitorwithdexamethasoneandanxpo1inhibitortotargettcellacutelymphoblasticleukemia AT segersheidi combinationtherapyofapsen1selectivegsecretaseinhibitorwithdexamethasoneandanxpo1inhibitortotargettcellacutelymphoblasticleukemia AT coolsjan combinationtherapyofapsen1selectivegsecretaseinhibitorwithdexamethasoneandanxpo1inhibitortotargettcellacutelymphoblasticleukemia |